Technology

NASA Invites Media, Public to Solar Eclipse Events in April

Published

2 years ago

February 28, 2024

WASHINGTON, Feb. 28, 2024 /PRNewswire/ — On Monday, April 8, a total solar eclipse will cross North America, giving people in 15 states the opportunity to see the Moon completely block the Sun, revealing our star’s relatively faint corona.

“This year’s total solar eclipse will be at least partially visible to all in the contiguous United States, making it the most accessible eclipse this nation has experienced in this generation,” said Nicola Fox, associate administrator, Science Mission Directorate at NASA Headquarters in Washington. “There is space for everyone to join NASA in experiencing this beautiful amalgamation of our Earth, Sun and Moon in an alignment that will not only lead to new scientific discoveries, but an incredible shared moment of inspiration and awe.”

The total solar eclipse will be visible along a narrow band stretching from Texas to Maine in the United States. Outside of this path, people in all 48 contiguous U.S. states will have the opportunity to see a partial eclipse, when the Moon covers only part of the Sun. Learn how to safely view this celestial event on NASA’s eclipse website.

NASA is joining with organizations, local governments, universities, science centers, and more for in-person events to engage the public and share the excitement of the solar eclipse. Information about these and additional events is available on NASA’s eclipse website.

To request a remote or in-person eclipse interview with NASA, please contact agency-eclipsemedia@mail.nasa.gov.

Location details and information for public and media attendance for select events is below:

Waco, Texas: STEAMclipse festival on April 6

For the public: The festival is open to the public, with no registration required.For media: Contact Taryn Courville (taryn.courville@esc12.net) for access information.

Events on April 8:
Kerrville, Texas: Kerrville Eclipse Festival at Louise Hays Park

For the public: Space in the event cannot be reserved and you will not need a ticket to enter. Limited off-site parking will be available to reserve ahead of the eclipse. Details are available online.For media: Request access online by Thursday, March 28.

Stonewall, Texas: Eclipse viewing at LBJ National Historical Park

For the public: The event is free and open to the public. No registration is required, but attendance is limited to the first 1,000 cars on April 8. More information is available online.For the media: Contact Cynthia Dorminey (cynthia_dorminey@nps.gov) for access information.

Austin, Texas: Eclipse viewing at the Austin Central Library

For the public: 10 a.m. – 2:30 p.m. on April 8, with free public talks, children’s activities, and a solar telescope.For media: Contact Ian O’Neill (ian.j.oneill@jpl.nasa.gov) for access information.

Waco, Texas: Eclipse Over Texas: Live From Waco!

For the public: Tickets required.For the media: Media can request access online.

Dallas: Eclipse viewing at the Dallas Arboretum

For the public: Admission tickets are sold out. More information is available online.For the media: Contact Terry Lendecker (tlendecker@dallasarboretum.org) for access information; space is limited.

Sun, Moon, and You at the Dallas Cotton Bowl

For the public: Free tickets required, check back online for more details.For media: Contact John Leslie (john.leslie@noaa.gov) for access information.

Russellville, Ark.: Eclipse events in multiple locations

For the public: Many events are free with no registration required; some events require tickets with details available online.For media: Contact Christie Graham (cgraham@discoverrussellville.org) for access information.

Carbondale, Ill.: Southern Illinois Crossroads Eclipse Festival

For the public: Tickets are required; information is available online.For media: Contact Tim Crosby (crosby@siu.edu) for access information.

Indianapolis: Eclipse viewing at Indianapolis Motor Speedway

For the public: Tickets are required for guests over 18; information is available online.For media: Contact mediacreds@brickyard.com for credentials by Wednesday, March 27.

Cleveland: Total Eclipse Fest at the Great Lakes Science Center

For the public: Event is free and open to the public with no registration required; information is available online.For media: Contact Joe Yachanin (yachaninj@glsc.org), marketing and communications director, Great Lakes Science Center, for access information.

Erie, Pa.: Eclipse viewing at Mercyhurst University

For the public: Event is free and open to the public with no registration required; information is available online.For media: Contact Christine Temple (cvb1@visiterie.com) for access information.

Niagara Falls, N.Y.: Eclipse events in multiple locations

For the public: Many events are free and open to the public, and registration may be required based on space constraints. Information is available online.For media: Contact Angela Berti (Angela.Berti@parks.ny.gov) for Niagara Falls State Park access information and Sarah Harvey (sharvey@niagarafallsusa.com) for access information on other events.

Houlton, Maine: Eclipse events in multiple locations

For the public: Eclipse viewing in downtown Houlton on April 8 is free and open to the public.For media: Contact Darcy Elburn (darcy.e.elburn@nasa.gov) for access information.

Washington: Solar Eclipse Festival on the National Mall

For the public: Event is free and open to the public with no registration required; information is available online.For media: Contact Amy Stamm (StammA@si.edu) for access information.

NASA will host live coverage of the eclipse on NASA+, the agency’s website, and the NASA app from 1 to4 p.m. EDT on April 8. NASA also will stream the broadcast live on its Facebook, X, YouTube, and Twitch social media accounts, as well as a telescope-only feed of eclipse views on the NASA TV media channel and YouTube.

To learn more about the total solar eclipse, visit:

go.nasa.gov/Eclipse2024

View original content to download multimedia:https://www.prnewswire.com/news-releases/nasa-invites-media-public-to-solar-eclipse-events-in-april-302074821.html

SOURCE NASA

Technology

Baidu to Report First Quarter 2026 Financial Results on May 18, 2026

Published

59 minutes ago

April 23, 2026

BEIJING, April 23, 2026 /PRNewswire/ — Baidu, Inc. (Nasdaq: BIDU; HKEX: 9888 (HKD Counter) and 89888 (RMB Counter)) (“Baidu” or the “Company”), a leading AI company with strong Internet foundation, today announced that it will report its financial results for the First Quarter 2026 ended March 31, 2026, before the U.S. market opens on May 18, 2026. Baidu’s management will hold an earnings conference call at 8:00 AM on May 18, 2026, U.S. Eastern Time (8:00 PM on May 18, 2026, Beijing Time).

Please register in advance of the conference call using the link provided below. It will automatically direct you to the registration page of “Baidu Inc. Q1 2026 Earnings Conference Call”. Please follow the steps to enter your registration details, then click “Register”. Upon registering, you will then be provided with the dial-in number, the passcode, and your unique access PIN. This information will also be emailed to you as a calendar invite.

For pre-registration, please click:
https://s1.c-conf.com/diamondpass/10054331-iu876y.html

In the 10 minutes prior to the call start time, you may use the conference access information (including dial-in number(s), the passcode and unique access PIN) provided in the calendar invite that you have received following your pre-registration.

Additionally, a live and archived webcast of this conference call will be available at https://ir.baidu.com.

A replay of the conference call may be accessed by phone at the following number until May 25, 2026:
US: 1 855 883 1031
Reply PIN: 10054331

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation, trading on Nasdaq under “BIDU” and the HKEX under “9888.” One Baidu ADS represents eight Class A ordinary shares.

View original content:https://www.prnewswire.com/news-releases/baidu-to-report-first-quarter-2026-financial-results-on-may-18-2026-302751204.html

SOURCE Baidu, Inc.

Technology

Phase 1 of 139th Canton Fair Introduces New Dedicated Product Zones as Emerging Technologies Take Center Stage

Published

59 minutes ago

April 23, 2026

GUANGZHOU, China, April 23, 2026 /PRNewswire/ — The 139th China Import and Export Fair (Canton Fair) has further optimized its exhibition landscape with nine new dedicated product zones, reflecting ongoing structural shifts in global trade and the continued upgrading of China’s export portfolio.

Among the most closely watched additions in Phase 1 are the consumer and agricultural drone zones, both making their debut at the Canton Fair and offering a focused showcase of applications in the low‑altitude economy. The consumer drone zone showcases progress in flight control, AI‑based obstacle avoidance and energy efficiency across imaging, tourism, emergency response and patrol. The agricultural drone zone highlights precision farming, with spraying, seeding and field‑management demonstrations showing terrain‑following, intelligent route planning, and precise payload control.

On day one, a Shandong‑based drone manufacturer welcomed buyers from 30+ countries, with over 50 strong leads. One buyer, after seeing load and wind‑resistance demonstrations, immediately confirmed three sample units and even proposed becoming a regional distributor.

Display technology is another focal point of Phase 1, highlighting advances in color accuracy, energy efficiency, and overall visual performance. Developments in fine‑grained control, expanded color gamut, and reduced power consumption point to a clear trend toward immersive viewing experiences combined with sustainability gains.

The smart wearables zone underscores how intelligent devices are becoming key interfaces for human‑machine interaction. From real‑time language translation and adaptive noise cancellation to long‑term health monitoring and AI‑enabled eyewear, wearables are evolving from standalone products into integrated systems that support communication, well‑being, and productivity across daily and professional settings.

The service robots zone further illustrates how artificial intelligence is moving from conceptual exploration to large‑scale deployment. Advanced robots showcased across industrial, commercial, medical, and public‑service scenarios demonstrate growing autonomy, multi‑sensory perception, and closer human-robot collaboration.

By bringing emerging technologies into clearer focus through dedicated zones, the 139th Canton Fair is reinforcing its function as a platform where trade trends take shape, innovation meets application, and global buyers gain early insights into cutting-edge technologies.

For pre-registration, please click: https://buyer.cantonfair.org.cn/register/buyer/email?source_type=16

Photo – https://mma.prnewswire.com/media/2963958/1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/phase-1-of-139th-canton-fair-introduces-new-dedicated-product-zones-as-emerging-technologies-take-center-stage-302751520.html

Technology

OZMOSI Announces Strategic Partnership with Planview to Advance AI-Driven Planning in Pharmaceutical R&D

Published

59 minutes ago

April 23, 2026

By combining structured clinical intelligence with AI-driven portfolio planning, the partnership gives pharmaceutical teams a faster, clearer way to make high-stakes R&D decisions

SPRING LAKE HEIGHTS, N.J., April 23, 2026 /PRNewswire/ — OZMOSI, a leading provider of structured pharmaceutical development intelligence, today announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD).

By integrating OZMOSI’s machine-readable clinical datasets directly into Planview’s AI-driven portfolio planning platform, external scientific data is now connected to internal R&D planning in one system, helping pharmaceutical organizations better predict market shifts, prioritize R&D investments, and make faster, more confident decisions.

This integration brings external clinical reality into internal R&D decision-making, so teams can plan based on what’s actually happening, not just on what they hope will happen.

The two organizations combine deep expertise in complementary areas, united by a shared focus on improving the quality and usability of data for strategic decision-making. OZMOSI provides structured, machine-readable intelligence across clinical trials, drug development programs, regulatory activity, and scientific literature, built on a consistent taxonomy that standardizes how data is connected and understood. Planview’s platform enables organizations to model complex investment scenarios, align initiatives with corporate strategy, and optimize resource allocation.

Together, these capabilities give teams a clearer, more complete view of the R&D landscape, grounded in clean, standardized data and strengthened by AI-driven analysis.

“AI is only as powerful as the data that fuels it,” said Beau Bush, President and Founder of OZMOSI. “Pharmaceutical organizations have no shortage of data, but too often it’s fragmented, inconsistent, and difficult to operationalize. By bringing OZMOSI’s structured data foundation together with Planview’s AI-driven planning capabilities, we’re enabling teams to move beyond disconnected analysis and toward truly integrated, forward-looking decision-making.”

“Strategic planning in pharmaceutical R&D is becoming increasingly dependent on advanced analytics and AI,” said Louise Allen, Chief Product Officer at Planview. “Integrating OZMOSI’s clinical intelligence into Planview’s platform enables pharmaceutical leaders to make better decisions by combining trusted external data with AI-driven planning

OZMOSI’s dataset spans more than 800,000 clinical trials, over 35,000 drugs, and 4,000 diseases and conditions. It brings together insights from clinical trial registries, regulatory filings, scientific literature, company disclosures, and industry announcements into a unified, structured dataset.

When integrated into Planview’s platform, this intelligence enables pharmaceutical and biotech organizations to evaluate competitive landscapes, identify emerging clinical trends, and simulate portfolio outcomes with unprecedented precision.

Together, OZMOSI and Planview are redefining how pharmaceutical organizations approach R&D strategy, ensuring that investment decisions are guided by accurate, standardized, and AI-ready data. By combining internal portfolio visibility with a continuously updated external view of the market, the partnership helps leaders not only understand what they have, but what to do next.

About OZMOSI

Founded in 2013, OZMOSI specializes in transforming complex pharmaceutical R&D intelligence into structured, machine-readable data. The company provides the foundation needed for accurate competitive analysis, product forecasting, and portfolio strategy. Through its proprietary taxonomy and semantic layer, OZMOSI connects fragmented data across the pharmaceutical ecosystem, enabling faster, more confident decision-making for global pharma, biotech, and investment teams.

Based in Spring Lake Heights, New Jersey, OZMOSI is focused on making pharmaceutical intelligence clear, usable, and ready for the future of AI-driven strategy. Learn more at www.ozmosi.com.

About Planview

Planview is the leading end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD), powered by advanced AI capabilities that give business and technology leaders the strategic foresight to prioritize investments and initiatives, make plans real within constraints, and pivot with certainty when things change. Our AI-driven connected platform of solutions underpins the business and digital transformations of more than 3,000 customers and 3.1 million users globally. Headquartered in Austin, Texas, Planview has over 1,500 employees worldwide. Learn more at www.planview.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ozmosi-announces-strategic-partnership-with-planview-to-advance-ai-driven-planning-in-pharmaceutical-rd-302750944.html

SOURCE Ozmosi Company